Expression, specificity and immunotherapy potential of prostate-associated genes in murine cell lines

Michael E. Grossmann, Monique Wood, Esteban Celis

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

The TRAMP-C1 (Cl) and TRAMP-C2 (C2) cell lines were derived from a prostate tumor that arose in a mouse from the transgenic adenocarcinoma mouse prostate (TRAMP) model. However, their similarity to primary prostate tumors and therefore their usefulness in immunotherapy studies has not been clearly denned. We showed using RT-PCR that these cell lines exhibited a variety of prostate-specific genes expressed by human prostate tumors that may be used as tumor-associated antigens for immunotherapy. Interestingly, several of these genes are also expressed in cell lines that are not prostatic in origin. The prostate cell lines were also shown to grow in an androgen-independent manner, to be capable of expressing MHC class I and to be susceptible to specific lysis by cytotoxic T lymphocytes. Therefore, these cell lines will provide us with the ability to evaluate immune responses to and tolerance of prostate-specific protein peptides in an animal model.

Original languageEnglish (US)
Pages (from-to)365-370
Number of pages6
JournalWorld Journal of Urology
Volume19
Issue number5
DOIs
StatePublished - Jan 1 2001

Fingerprint

Immunotherapy
Prostate
Cell Line
Genes
Transgenic Mice
Adenocarcinoma
Neoplasms
Cytotoxic T-Lymphocytes
Neoplasm Antigens
Androgens
Animal Models
Polymerase Chain Reaction
Peptides

ASJC Scopus subject areas

  • Urology

Cite this

Expression, specificity and immunotherapy potential of prostate-associated genes in murine cell lines. / Grossmann, Michael E.; Wood, Monique; Celis, Esteban.

In: World Journal of Urology, Vol. 19, No. 5, 01.01.2001, p. 365-370.

Research output: Contribution to journalArticle

@article{fca15c85f236456b8c13e2e2f421abb4,
title = "Expression, specificity and immunotherapy potential of prostate-associated genes in murine cell lines",
abstract = "The TRAMP-C1 (Cl) and TRAMP-C2 (C2) cell lines were derived from a prostate tumor that arose in a mouse from the transgenic adenocarcinoma mouse prostate (TRAMP) model. However, their similarity to primary prostate tumors and therefore their usefulness in immunotherapy studies has not been clearly denned. We showed using RT-PCR that these cell lines exhibited a variety of prostate-specific genes expressed by human prostate tumors that may be used as tumor-associated antigens for immunotherapy. Interestingly, several of these genes are also expressed in cell lines that are not prostatic in origin. The prostate cell lines were also shown to grow in an androgen-independent manner, to be capable of expressing MHC class I and to be susceptible to specific lysis by cytotoxic T lymphocytes. Therefore, these cell lines will provide us with the ability to evaluate immune responses to and tolerance of prostate-specific protein peptides in an animal model.",
author = "Grossmann, {Michael E.} and Monique Wood and Esteban Celis",
year = "2001",
month = "1",
day = "1",
doi = "10.1007/PL00007104",
language = "English (US)",
volume = "19",
pages = "365--370",
journal = "World Journal of Urology",
issn = "0724-4983",
publisher = "Springer Verlag",
number = "5",

}

TY - JOUR

T1 - Expression, specificity and immunotherapy potential of prostate-associated genes in murine cell lines

AU - Grossmann, Michael E.

AU - Wood, Monique

AU - Celis, Esteban

PY - 2001/1/1

Y1 - 2001/1/1

N2 - The TRAMP-C1 (Cl) and TRAMP-C2 (C2) cell lines were derived from a prostate tumor that arose in a mouse from the transgenic adenocarcinoma mouse prostate (TRAMP) model. However, their similarity to primary prostate tumors and therefore their usefulness in immunotherapy studies has not been clearly denned. We showed using RT-PCR that these cell lines exhibited a variety of prostate-specific genes expressed by human prostate tumors that may be used as tumor-associated antigens for immunotherapy. Interestingly, several of these genes are also expressed in cell lines that are not prostatic in origin. The prostate cell lines were also shown to grow in an androgen-independent manner, to be capable of expressing MHC class I and to be susceptible to specific lysis by cytotoxic T lymphocytes. Therefore, these cell lines will provide us with the ability to evaluate immune responses to and tolerance of prostate-specific protein peptides in an animal model.

AB - The TRAMP-C1 (Cl) and TRAMP-C2 (C2) cell lines were derived from a prostate tumor that arose in a mouse from the transgenic adenocarcinoma mouse prostate (TRAMP) model. However, their similarity to primary prostate tumors and therefore their usefulness in immunotherapy studies has not been clearly denned. We showed using RT-PCR that these cell lines exhibited a variety of prostate-specific genes expressed by human prostate tumors that may be used as tumor-associated antigens for immunotherapy. Interestingly, several of these genes are also expressed in cell lines that are not prostatic in origin. The prostate cell lines were also shown to grow in an androgen-independent manner, to be capable of expressing MHC class I and to be susceptible to specific lysis by cytotoxic T lymphocytes. Therefore, these cell lines will provide us with the ability to evaluate immune responses to and tolerance of prostate-specific protein peptides in an animal model.

UR - http://www.scopus.com/inward/record.url?scp=0035512419&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035512419&partnerID=8YFLogxK

U2 - 10.1007/PL00007104

DO - 10.1007/PL00007104

M3 - Article

C2 - 11760786

AN - SCOPUS:0035512419

VL - 19

SP - 365

EP - 370

JO - World Journal of Urology

JF - World Journal of Urology

SN - 0724-4983

IS - 5

ER -